The CXCL8/CXCR2 axis emerges as a master regulator of tumor neovascularization, activating ERK1/2 and PI3K pathways in human intestinal microvascular endothelial cells (HIMECs) to drive proliferation, migration, and tubulogenesis. The gene discussed is CXCR2; the disease is neoplasm.